Results 191 to 200 of about 13,859,586 (381)

A Follow up Study of Osteogenic Sarcoma [PDF]

, 1961
S. Cederlöf, T Hiertonn, E. Salén
openalex   +1 more source

Adjunct ketamine treatment of depression in treatment-resistant schizophrenia patients is unsatisfactory in pilot and secondary follow-up studies. [PDF]

Brain Behav, 2020
Zhuo C, Lin X, Tian H, Liu S, Bian H, Chen C.   +5 more
europepmc   +1 more source

Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer

Molecular Oncology, EarlyView.
This study employed targeted metabolomic profiling to identify 302 distinct metabolites present in platelet‐rich plasma (PRP), revealing aberrant metabolic profiles amongst individuals diagnosed with colorectal cancer (CRC). Compared to carcinoembryonic antigen (CEA) and cancer antigen 19‐9 (CA199), our metabolite panel showed improved sensitivity ...
Zuojian Hu, Fenglin Shen, Yang Liu, Ziqing Zhong, Yongling Chen, Zhiyuan Xia, Cuiju Mo, Hongxiu Yu   +7 more
wiley   +1 more source

Incidence of Hypertension among Lead Workers: A Follow-up Study based on Regular Control over 20 years

, 1966
K. Cramér, Linda L. Dahlberg
openalex   +1 more source

Follow-up studies of renal function in patients with spinal cord injuries of traumatic origin [PDF]

, 1968
Mary Price
openalex   +1 more source

Inhibition of acyl‐CoA synthetase long‐chain isozymes decreases multiple myeloma cell proliferation and causes mitochondrial dysfunction

Molecular Oncology, EarlyView.
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy, Heather Fairfield, Victoria E. DeMambro, Samaa Fadel, Carlos A. Gartner, Michelle Karam, Christian Potts, Princess Rodriguez, Ya‐Wei Qiang, Habib Hamidi, Xiangnan Guan, Calvin P. H. Vary, Michaela R. Reagan   +12 more
wiley   +1 more source

A four year follow‐up of suspected rheumatoid arthritis: The Tecumseh, Michigan, community health study

, 1969
William M. Mikkelsen, H.J. Dodge
openalex   +1 more source

Bayesian Effect Size Ranking to Prioritise Genetic Risk Variants in Common Diseases for Follow-Up Studies. [PDF]

Genet Epidemiol
Crouch DJM, Inshaw JRJ, Robertson CC, Ng E, Zhang JY, Chen WM, Onengut-Gumuscu S, Cutler AJ, Sidore C, Cucca F, Pociot F, Concannon P, Rich SS, Todd JA.   +13 more
europepmc   +1 more source

Participant retention in trauma intensive care unit (ICU) follow-up studies: a post-hoc analysis of a previous scoping review. [PDF]

Trauma Surg Acute Care Open, 2020
Rawal H, Young DL, Nikooie R, Al Ani AH, Friedman LA, Vasishta S, Haut ER, Colantuoni E, Needham DM, Dinglas VD.   +9 more
europepmc   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source